Endocrine Updates

Teplizumab: 1 Step Forward in Type 1 Diabetes

Yves Jean Y. Liong, MD, FPCP, DPCEDM Type 1 diabetes is an autoimmune condition that destroys pancreatic β cells,

The New Steatotic Liver Disease Subclassification and the New MASH-targeted Pharmacotherapy: Resmetirom

By Maria Nikki Cruz, MD Steatotic Liver Disease (SLD) has various etiologies (Figure 1). Metabolic dysfunction-associated steatotic liver disease (MASLD),

Finerenone: New Kid on the Block in Diabetic Kidney Disease

By Julie Anne Gabat-Tan, MD, FPCP, FPCEDM and Gretchen Ang-Manuel, MD, FPCP De La Salle University Medical Center Diabetes is

CHASING SHADOWS: The Search For Clarity

Kayla Pamela dela Cerna, MD; Estherly Grace Gonzales, MD; Aaron Ciel Perez, MD; Bernadette Diane Vista, MD; Oliver Allan C.

ENDOCRINE CROSSWORD: 2024 Diabetes Updates

CROSSWORD Karen Ilagan Vega, FPCP, FPCEDM PLAY THE GAME! https://crosswordlabs.com/view/2024-diabetes-updates Contest Mechanics: 1. Solve the word search puzzle and screen

Funny Patient Encounters

Maria Nikki Cruz-Arce, MD

PCEDM Office
Find Us On The Map

Email Us
sec@endo-society.org.ph

Quick Links

Latest Posts

SICEM2025

February 19, 2025

The Perfect Storm

January 11, 2025

Paskong Pinoy: HbA1c Highs sa Gitna ng Kapaskuhan

January 11, 2025

Gallery

What is PCEDM?

The PCEDM is a sub-specialty society of the Philippine College of Physicians, a founding member of the ASEAN Federation of Endocrine Societies, and a member of the International Society of Endocrinology.

Learn More >>